Indazol derived Compounds, inhibitors of Janus Kinase (JAK)； Pharmaceutical composition that comprises； and its use to treat allergic rhinitis, nasal congestion, Asthma, chronic bronchitis, arthritis, heart disease, ulcerative colitis, Bacterial and viral infection, cancer, and Alzheimer's disease. Among other diseases.
The present invention relates to compounds of formula (I): to pharmaceutically acceptable salts therefore and to pharmaceutically acceptable solvates of said compounds and salts, wherein the substituents are defined herein； to compositions containing such compounds； and to the uses of such compounds in the treatment of various diseases, particularly asthma and COPD.COMPUESTOS DERIVADOS DE INDAZOL, INHIBIDORES JAK； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； Y SU USO EN EL TRATAMIENTO DE RINITIS ALERGICAS, CONGESTION NASAL, ENFERMEDADES INFLAMATORIAS, CARDIACAS, OSEAS, ENTRE OTRAS.
